BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19032829)

  • 1. Anti-glucose-6-phosphate isomerase, anti-cyclic citrullinated peptide antibodies and HLA-DRB1 genotypes in Japanese patients with early rheumatoid arthritis.
    Furuya T; Matsumoto I; Tsuchiya N; Hakoda M; Ichikawa N; Yago T; Higami K; Nanke Y; Sumida T; Kamatani N; Kotake S
    Clin Exp Rheumatol; 2008; 26(5):918-21. PubMed ID: 19032829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide.
    Furuya T; Hakoda M; Ichikawa N; Higami K; Nanke Y; Yago T; Kobashigawa T; Tokunaga K; Tsuchiya N; Kamatani N; Kotake S
    Clin Exp Rheumatol; 2007; 25(2):219-24. PubMed ID: 17543145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
    Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-citrullinated glucose-6-phosphate isomerase peptide antibodies in patients with rheumatoid arthritis are associated with HLA-DRB1 shared epitope alleles and disease activity.
    Umeda N; Matsumoto I; Ito I; Kawasaki A; Tanaka Y; Inoue A; Tsuboi H; Suzuki T; Hayashi T; Ito S; Tsuchiya N; Sumida T
    Clin Exp Immunol; 2013 Apr; 172(1):44-53. PubMed ID: 23480184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DRB1*0404 is strongly associated with high titers of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
    Charpin C; Balandraud N; Guis S; Roudier C; Toussirot E; Rak J; Lambert N; Martin M; Reviron D; Roudier J; Auger I
    Clin Exp Rheumatol; 2008; 26(4):627-31. PubMed ID: 18799094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
    Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC
    Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients.
    Farouk HM; Mansour HE; Rahman SA; Mostafa AA; Shamy HA; Zarouk WA
    Braz J Med Biol Res; 2009 Sep; 42(9):831-8. PubMed ID: 19738989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide.
    van der Helm-van Mil AH; Verpoort KN; le Cessie S; Huizinga TW; de Vries RR; Toes RE
    Arthritis Rheum; 2007 Feb; 56(2):425-32. PubMed ID: 17265477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies.
    Louzada-Júnior P; Freitas MV; Oliveira RD; Deghaide NH; Conde RA; Bertolo MB; Donadi EA
    Braz J Med Biol Res; 2008 Jun; 41(6):493-9. PubMed ID: 18560674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
    Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
    Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
    Huizinga TW; Amos CI; van der Helm-van Mil AH; Chen W; van Gaalen FA; Jawaheer D; Schreuder GM; Wener M; Breedveld FC; Ahmad N; Lum RF; de Vries RR; Gregersen PK; Toes RE; Criswell LA
    Arthritis Rheum; 2005 Nov; 52(11):3433-8. PubMed ID: 16255021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
    Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
    Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
    Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
    Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.
    Linn-Rasker SP; van der Helm-van Mil AH; van Gaalen FA; Kloppenburg M; de Vries RR; le Cessie S; Breedveld FC; Toes RE; Huizinga TW
    Ann Rheum Dis; 2006 Mar; 65(3):366-71. PubMed ID: 16014670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis.
    Kaltenhäuser S; Pierer M; Arnold S; Kamprad M; Baerwald C; Häntzschel H; Wagner U
    Rheumatology (Oxford); 2007 Jan; 46(1):100-4. PubMed ID: 16728439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
    Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
    Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American Native population with rheumatoid arthritis and their first-degree relatives.
    El-Gabalawy HS; Robinson DB; Hart D; Elias B; Markland J; Peschken CA; Smolik I; Montes-Aldana G; Schroeder M; Fritzler MJ; Cheang M; Oen K
    J Rheumatol; 2009 Jun; 36(6):1130-5. PubMed ID: 19411392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of HLA-DRB1*09:01 and *04:05 with smoking suggests distinctive mechanisms of rheumatoid arthritis susceptibility beyond the shared epitope.
    Bang SY; Lee HS; Lee KW; Bae SC
    J Rheumatol; 2013 Jul; 40(7):1054-62. PubMed ID: 23637323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.
    Jiang X; Trouw LA; van Wesemael TJ; Shi J; Bengtsson C; Källberg H; Malmström V; Israelsson L; Hreggvidsdottir H; Verduijn W; Klareskog L; Alfredsson L; Huizinga TW; Toes RE; Lundberg K; van der Woude D
    Ann Rheum Dis; 2014 Oct; 73(10):1761-8. PubMed ID: 24812286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.